You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 285 No. 18, May 9, 2001 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (10)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Oncology
 •Oncology, Other
 •Gastroenterology
 •Gastrointestinal Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Surgical Therapy for Reflux Disease

Peter J. Kahrilas, MD

JAMA. 2001;285:2376-2378.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

With publication of a follow-up report on the Department of Veterans Affairs cooperative trial comparing long-term outcomes of medical and surgical therapy for gastroesophageal reflux disease (GERD) by Spechler et al in this issue of THE JOURNAL,1 it is clear that the decision to pursue antireflux surgery has not gotten any simpler. The status of the medical and surgical cohorts is reported 10 to 13 years after initial enrollment in the trial making this report the most complete, longest-term, and most carefully collected data available. By all standards, these patients had severe GERD, evident by the high proportion who had esophageal ulcers, strictures, or Barrett esophagus at baseline. Common wisdom argues that this is the group most likely to benefit from antireflux surgery: surgical correction is long-lasting, replaces antisecretory medications, and eliminates the subsequent cancer risk—or so the argument goes.

The major findings reported by Spechler . . . [Full Text of this Article]

Author Affiliation: Department of Medicine, Northwestern University Medical School, Chicago, Ill.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Long-term Outcome of Medical and Surgical Therapies for Gastroesophageal Reflux Disease: Follow-up of a Randomized Controlled Trial
, , , , , , , , , , , , and
JAMA. ;285():2331-2338.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Surgery Is Not the Treatment of Choice for GERD
JWatch Gastroenterology 2001;2001:1-1.
FULL TEXT  

Surgery Is Less Beneficial for Severe GERD than We Thought
JWatch General 2001;2001:4-4.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.